Debesh Mandal Profile
Debesh Mandal

@debesh_man

Followers
368
Following
1K
Media
77
Statuses
3K

Co-founder and CEO @nanograb (YC S23)

London
Joined January 2012
Don't wanna be here? Send us removal request.
@debesh_man
Debesh Mandal
19 hours
As humanity becomes lazier, alpha will be found in motivating others.
0
0
0
@debesh_man
Debesh Mandal
3 days
the contrarian play right now is building a biotech platform company.
0
0
0
@debesh_man
Debesh Mandal
5 days
If you randomly picked 100 "decent" companies and randomly invested $400k them, you would probably 3x your fund. Hmm, now where could I find 100 companies to invest in quickly?.
@PeterJ_Walker
Peter Walker
13 days
Early stage VCs should (probably, on average) make more investments. Lots of objections, some of them very valid. But the general disdain for "spray and pray" is pretty anti-math. Link to the full argument as laid out by @credistick in following post
Tweet media one
0
0
1
@debesh_man
Debesh Mandal
6 days
DeSci is fascinating - a community that evolves like a startup edging towards PMF. Keeping an eye here and feeling more hopeful and optimistic compared to other areas of crypto.
@paulkhls
Paul Kohlhaas bio/acc
13 days
In t-35 days the next phase of DeSci begins - autonomous superintelligent science powered by internet capital markets using $BIO - turn notis on if you want to be early. DeSci is in its earliest phases - this is a lifelong journey for me, I'm in year 7. But most of you reading.
0
0
1
@debesh_man
Debesh Mandal
6 days
Very cool.
@jakublala
Jakub Lála 🦸‍♂️
6 days
🚨 Excited to share the first major project of my PhD: BAGEL, a modular, model-agnostic, fully customizable Python framework for programmable protein design 🧬🥯.Code (BAGEL) 💻: Code (boileroom) ⚙️: Preprint 📜:
0
1
3
@debesh_man
Debesh Mandal
7 days
We are still at the beginning of AI-enabled drug discovery.
@biogerontology
Alex Zhavoronkov, PhD (aka Aleksandrs Zavoronkovs)
14 days
My dear friends, I have a great story to share. After a night of hard work, one of my agents working on real-time monitoring of publications related to targets of interest informed me of a high-profile publication on TNIK. And when I clicked on the link, I almost fell out of my
Tweet media one
0
0
0
@debesh_man
Debesh Mandal
8 days
Leaving Be Biopharma (B-cell focused platform) here as a guess that is not delivery focused.
0
0
0
@debesh_man
Debesh Mandal
11 days
Regenerating lifespan from within is the future of human health.
@garrytan
Garry Tan
11 days
Best possible white pill scenario about healthcare costs going to zero on a long enough timeframe (likely via ASI).
0
0
1
@debesh_man
Debesh Mandal
11 days
$BEAM acquiring early stage co - my hunch is that it’s a delivery company.
@yaireinhorn
Yair Einhorn
11 days
1/🚨🚨WOW! @BeamTx has entered into a merger agreement in which it acquired an undisclosed (!!) early-stage life sciences company! As part of the acquisition agreement - which was already signed on 7/1/25 - $BEAM has issued to the undisclosed company’s shareholders 403,128 BEAM
Tweet media one
1
0
2
@debesh_man
Debesh Mandal
13 days
I'm sure that cell peturbation data is useful in understanding how cells work but what I hope is that we will learn how to transfer these learnings to human systems.
1
0
0
@debesh_man
Debesh Mandal
13 days
$PRME 2.5x-ing and $EDIT 1.5x-ing in the last month is a solid sign of times to come for genetic medicines on top of all the M&A activity on in vivo cell therapies.
0
0
2
@debesh_man
Debesh Mandal
13 days
RT @BowTiedBiotech: 14/ 🧬 Final Question: Who’s Next?. Which still-private biotech platform is:. 🔸 In human studies.🔸 Showing IND velocity….
0
2
0
@debesh_man
Debesh Mandal
14 days
House taste is exactly what @MenePangalos warned us about at the @NucleateUK forum a few weeks ago.
@sarthakgh
Sar Haribhakti
14 days
"Every winery I go to, they truly believe that their wine is the best in the world. Why do they believe that? They often have worked there for 10 years, 20 years. House taste is therefore a dangerous concept for any company."
Tweet media one
0
0
0
@debesh_man
Debesh Mandal
15 days
RT @abbvie: JUST IN: We’ve signed a definitive agreement to acquire @capstantx, underscoring our commitment to drive scientific innovation….
0
7
0
@debesh_man
Debesh Mandal
15 days
$ABBV acquiring targeted LNP company Capstan who have just dosed ph1 in vivo CAR-T therapy; $LLY acquired another targeted LNP company Verve Therapeutics a couple of weeks ago - is this the start of the boom loop?.
0
0
1
@debesh_man
Debesh Mandal
15 days
RT @paulg: I told them this was unlikely, but the uncertainty is enough to deter them. Much as uncertainty about tariffs is enough to disco….
0
25
0
@debesh_man
Debesh Mandal
20 days
My friend sometimes calls it “Y com-bee” but this is the same friend that says “Hundy P” so I’ll allow it.
@garrytan
Garry Tan
20 days
Please never call it “ycomb”.
0
0
2
@debesh_man
Debesh Mandal
22 days
Within minutes @newlimit make a release - super exciting times for reprogramming human health.
0
0
0
@debesh_man
Debesh Mandal
22 days
Does this mean “virtual cell” models are biotech’s answer to LLMs? If so, expect iso or recursion to release a rival model to this and Xaira’s release a couple of weeks ago.
@arcinstitute
Arc Institute
22 days
Introducing Arc Institute’s first virtual cell model: STATE
Tweet media one
1
0
1
@debesh_man
Debesh Mandal
23 days
RT @OdedRechavi: Students who started their PhD in 2020 and are about to graduate
Tweet media one
0
23
0